CORRELATION BETWEEN TONSIL HYPERTROPHY AND ALLERGIC RHINITIS IN CHILDREN

Gabriela Kopacheva-Barsova; Vesna Dukovska; Sofija Nikoloska; Dejan Trajkov

Gabriela Kopacheva-Barsova University Clinic for ENT, University Campus "St. Mother Theresa", Skopje, R of North Macedonia
Vesna Dukovska General Hospital "Remedika", Skopje, R of North Macedonia
Sofija Nikoloska University Clinic for ENT, University Campus "St. Mother Theresa", Skopje, R of North Macedonia
Dejan Trajkov Institute of Immunobiology and Human Genetics, Faculty of Medicine, University â€ž Ss. Cyril and Methodius, Skopje, R.of North Macedonia

Abstract

To show whether there is a correlation between the tonsils hypertrophy and adenoid hypertrophy (AH) with allergic rhinitis in children in R. Macedonia. A total of 120 children (5.3 Â± 1.2 years old) with tonsil hypertrophy, adenoid hypertrophy, persistent upper respiratory infections and consecutive nasal obstruction were examined, after their parents gave a verbal consent for their participation. Inclusion criteria were: frequent upper respiratory infections, angina, nasal congestion due to nasal obstruction caused by adenoid hypertrophy, frequent serous otitis due to adenoid hypertrophy and sleep apnea due to tonsil hypertrophy. The prevalence of allergic rhinitis (AR) was as follows: AR had 70% of children with concha nasal hypertrophy, 39.2% of children with tonsillar hypertrophy, and 78.3% of children with adenoid hypertrophy. Although in the group of children with adenoid hypertrophy, a more severe degree of nasal concha hypertrophy was registered in children with AR compared to children without AR, it was statistically not significant. Regarding children with adenoid hypertrophy (AH), the results showed that children with AR presented significantly different results for Parikh's scale (p = 0.0076). Obstruction of torus tubarius was more common in children with AR (86.8% vs. 61.2%), while these children had a finding of soft palate obstruction (9.4% vs. 26.8%), and vomer obstruction (3.8% vs. 11.9%) less often than children without AR. Our study found that almost half of the children with tonsillitis/adenoid hypertrophy had AR. Grade 3 and 4 TH was present in third of the children.

Keywords: allergic rhinitis, children, nasal concha, volume of palatine tonsils, volume of adenoid vegetation, correlation

References

1.Ciprandi G, Tosca MA, Signori A, Ameli F. Comparison between symptoms and endoscopy in children with nasal obstruction. Int J Pediatr Otorhinolaryngol. 2010; 74[12]: 1405-8. DOI: 10.1016/j.ijporl.2010.09.019.
2.Torretta S, Marchisio P, Esposito S, Cappadona M, Fattizzo M, Pignataro L. Diagnostic accuracy of the nasal obstruction index in detecting adenoid hypertrophy in children without allergy. Int J Pediatr Otorhinolaryngol. 2011; 75[1]: 57-61. DOI: 10.1016/j.ijporl.2010.10.007
3.Chawes BL. Upper and lower airway pathology in young children with allergic- and non-allergic rhinitis. Dan Med Bull. 2011; 58[5]: B4278.
4.Ameli F, Brocchetti F, Tosca MA, Signori A, Ciprandi G. Adenoidal hypertrophy and allergic rhinitis: is there an inverse relationship? Am J Rhinol Allergy. 2013; 27[1]: e5-10. DOI: 10.2500/ajra.2013.27.3854
5.Chadha NK, Zhang L, Mendoza-Sassi RA, CÃ©sar JA. Using nasal steroids to treat nasal obstruction caused by adenoid hypertrophy: does it work? Otolaryngol Head Neck Surg. 2009; 140[2]: 139-147. DOI: 10.1016/j.otohns.2008.11.008.
6.Varricchio A, La Mantia I, Brunese FP, Ciprandi G. Inflammation, infection, and allergy of upper airways: new insights from national and real-world studies; Ital J Pediatr. 2020; 46: 18. DOI: https://doi.org/10.1186/s13052-020-0782-z
7.Simmen BD. Medical and surgical treatment options in the management of upper airway diseases. Ther Umsch: 2008; 65[3]: 175-80. DOI: 10.1024/0040-5930.65.3.175.
8.Dykewicz MS. 7. Rhinitis and sinusitis. J Allergy Clin Immunol. 2003; 111[2 Suppl]: S520â€“S529. DOI: 10.1067/mai.2003.82.
9.Watkins DS, Lewis RH, Bascalin KA, Fisher PH, Peroni DJ, Garlepp MJ, Thompson PJ. Expression and localization of the inducible isoform of nitric oxide synthase in nasal epithelium. Clin Exp Allergy. 1998; 28[2]: 211â€“219. DOI: 10.1046/j.1365-2222.1998.00215.x.
10.Ciprandi G, Buscaglia S, Pesce G, Pronzato C, Ricca V, Parmiani S, Bagnasco M, Canonica GW. Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy. J Allergy Clin Immunol. 1995; 96[6 Pt 1]: 971â€“979. DOI: 10.1016/S0091-6749(95)70235-0.
11.Djiupesland GP, Chatkin MJ, Qian W, Haight SJJ. Nitric oxide in nasal airway: a new dimension in otorhinolaryngology; Am J Otolaryngol. 2001; 22[1]: 19â€“32.
12.Brandtzaeg P. Immunobarriers of the mucosa of the upper respiratory and digestive pathways. Acta Otolaryngol. 1988; 105[1-2]: 172â€“180. DOI: 10.3109/00016488809119462.
13.Stankiewicz J. Chronic sinusitis. In: Johnson JT, Yu VL, eds. Infectious diseases and antimicrobial therapy of the ears, nose and throat. Philadelphia: WB Saunders Co; 1997.
14.Varricchio A, La Mantia I, Brunese FP, Ciprandi G: Inflammation, infection, and allergy of upper airways: new insights from national and real-world studies. Ital J Pediatr. 2020; 46[1]: 18. DOI: 10.1186/s13052-020-0782-z.